New Study Explores Genetic Link Between GLP-1 Drugs and Male Pattern Hair Loss
A recent study published in the Journal of Investigative Dermatology proposes a new genetic mechanism that may help explain why some men experience hair loss while taking GLP-1 receptor agonist medications. The research suggests that these drugs could increase expression of the GLP1R gene, which is linked to male pattern baldness.
Hair Loss: A Rare but Documented Side Effect
GLP-1 drugs are commonly used for weight loss and type 2 diabetes management. While hair loss has been documented as a rare side effect, recent surveys indicate that approximately 20% of users experience hair shedding within the first year.
Mechanisms Behind GLP-1-Related Hair Loss
The study authors propose that GLP-1 medications activate receptors in hair follicles, potentially causing hair to enter a dormant phase and leading to loss. Dr. Varsha Babu, an endocrinologist with Inspire Health and division chief of endocrinology at UCSF Fresno, suggests this could be due to the physiological stress associated with weight loss.
GLP-1 Drugs Linked to Nail Disorders Too
In addition to hair loss, GLP-1 drugs have been linked to nail-related problems. A multinational survey found that 39% of patients using these medications reported nail detachment compared to only 9% in a control group.
💬 Comments (0)